Data & AI for Health & Pharmaceuticals

Transforming and creating value for pharmaceuticals, hospitals, clinicals, telemedicine, biotechnologies through the power of data & AI.

Increased investments in AI are driving innovation and efficiency

The global AI in healthcare market was valued at $19.54 billion in 2023 and is projected to reach $490.96 billion by 2032, with a CAGR of 43.2% (Grand View Research) (Fortune Business Insights).

Positive impact of data & AI in multiple areas for Health

Operational Efficiency: AI improves data analysis, with machine learning helping to structure 97% of previously unused healthcare data. (Healthtech Solutions).
Medical Imaging and Diagnostics: AI tools enhance diagnostic accuracy and reduce interpretation times for medical images, aiding in early disease detection. (Healthtech Solutions) (Grand View Research).

Shorter Time to Market and improved patient experience

Drug Discovery and Development: AI reduces drug discovery times from 5-6 years to just one year, significantly speeding up the process. (Grand View Research) (PwC).
Personalized Medicine: AI analyzes genomic and medical data to develop personalized treatment plans, improving treatment efficacy. (Fortune Business Insights) (PwC).